Eyenovia Slumps On Pricing Of Registered Direct Offering

(RTTNews) – Eyenovia Inc. (EYEN), a commercial-stage ophthalmic pharmaceutical technology company, today, announced the pricing of a $1.3 million registered direct offering.

admin